Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant
NCT01852591
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
BIOLOGICAL:
PCV 13
Sponsor
H. Lee Moffitt Cancer Center and Research Institute